Patient Adherence Program Planning

Patient Adherence Program Planning


Patient Adherence provides benchmarks, strategic recommendations and insights to help life science companies implement patient-centric initiatives to strengthen adherence. The report’s data were compiled from primary interviews and surveys with front-line marketing experts from more than 30 life science companies of all sizes and geographic locations. Armed with these data, teams will be prepared to overcome patient under-education, distrust and financial barriers.

  • This report is a guide to improving company approaches to patient adherence.
  • Companies are losing revenue and health outcomes suffer when patients are non-compliant with their treatment regimens. Implement patient-centric approaches to help strengthen adherence.
  • Build an adherence team:
    • See who is involved in adherence — ad hoc versus dedicated groups
    • Benchmark resources, structure and staffing for groups focused on patient adherence.
    • Develop a winning combination of patient adherence activities across a range of media, taking advantage of new technologies and gamification.
  • Description
  • Additional information

Report Details

This report provides patient adherence strategies, industry trends, organizational structure, staffing, and budgets supporting patient compliance initiatives. Life science companies rely on patient adherence strategies to reach a broad range of healthcare consumers, increase revenue and improve patient health outcomes.

  • Number of Chapters: 4
  • Number of Graphics: 98 + 5 Team Profiles
  • Number of Pages: 176

Data have been split by company type:

  • Top 10
  • Top 50
  • Small
  • Other

Scope of responsibility:

  • Global/headquarters
  • Regional/affiliate
  • Other (therapeutic area, single brand, business unit, etc.)

Data have been split by team region:

  • US
  • EU & Can
  • Rest-of-World

Profile Highlights and Content:

  • Team and Brand Background
    • Company size and team region/market
    • Team age and scope of responsibility
    • Functional oversight
    • Brand therapeutic area, annual sales revenue and market
    • Percentage of annual revenue lost through patient non-adherence
    • Percentage of annual revenue retained through adherence efforts
  • Patient Adherence Staffing
    • In-house and outsourced FTEs contributed from dedicated patient adherence groups as well as multiple crossfunctional teams
    • Expected increase in in-house and outsourced FTEs for dedicated teams and total patient adherence staffing
  • Adherence Budget Allocation
    • Total brand adherence budget from 2014-2017, where available
    • Percentage of budget outsourced
    • Percentage of budget dedicated to specific initiative channels and expenses
      • Digital
      • Mobile
      • Print
      • Patient organizations
      • Patient access
      • Salaries and overhead

Involve multiple internal functions in patient adherence program initiatives and planning: To implement patient adherence program activities, companies consider product labeling, reimbursement, side effects disclosures and other aspects relating to the patient experience. Involving input from several internal life science team functions brings knowledge and different perspectives to these initiatives. The study shows how to allocate resources to successfully conduct these activities.


Anticipate increasing patient adherence program budgets for digital patient compliance activities: Companies fund various initiative types to develop a well-rounded patient adherence program strategy. Initiatives can span multiple direct-to-user channels, including digital, mobile and print media. This report discusses how some groups work with patient organizations to provide support and encourage compliance among end users. Additionally, some initiatives offer rebates or financial assistance so that patients can more easily fill their prescriptions.


Select patient adherence vendors based on experience levels, reputation and understanding of target populations: Life science companies that do not have the internal resources needed to develop and implement patient adherence initiatives turn to experienced vendors. Patient Adherence discusses qualifications, knowledge bases, therapeutic area knowledge and innovation levels that life science companies consider when outsourcing these objectives.